WO2015173546A1 - Pansement pour drain chirurgical - Google Patents
Pansement pour drain chirurgical Download PDFInfo
- Publication number
- WO2015173546A1 WO2015173546A1 PCT/GB2015/051364 GB2015051364W WO2015173546A1 WO 2015173546 A1 WO2015173546 A1 WO 2015173546A1 GB 2015051364 W GB2015051364 W GB 2015051364W WO 2015173546 A1 WO2015173546 A1 WO 2015173546A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dressing
- absorbent body
- drain
- base
- compartment
- Prior art date
Links
- 230000002745 absorbent Effects 0.000 claims abstract description 53
- 239000002250 absorbent Substances 0.000 claims abstract description 53
- 239000000463 material Substances 0.000 claims abstract description 44
- 239000006260 foam Substances 0.000 claims abstract description 36
- 210000000416 exudates and transudate Anatomy 0.000 claims abstract description 11
- 239000000853 adhesive Substances 0.000 claims description 21
- 230000001070 adhesive effect Effects 0.000 claims description 21
- 229920001296 polysiloxane Polymers 0.000 claims description 11
- 239000012876 carrier material Substances 0.000 claims description 7
- 230000001464 adherent effect Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 4
- 229920005830 Polyurethane Foam Polymers 0.000 claims description 4
- 229940072056 alginate Drugs 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 239000011496 polyurethane foam Substances 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 3
- 229920002994 synthetic fiber Polymers 0.000 claims description 3
- 239000004758 synthetic textile Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000004750 melt-blown nonwoven Substances 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 2
- 229920006264 polyurethane film Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 229910052709 silver Inorganic materials 0.000 description 10
- 239000004332 silver Substances 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 239000003522 acrylic cement Substances 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 5
- 239000013464 silicone adhesive Substances 0.000 description 4
- 229920002413 Polyhexanide Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- -1 silver ions Chemical class 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 1
- 239000004821 Contact adhesive Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229920001090 Polyaminopropyl biguanide Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 210000003281 pleural cavity Anatomy 0.000 description 1
- 229940093424 polyaminopropyl biguanide Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/45—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
- A61F13/0209—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings comprising superabsorbent material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/022—Adhesive bandages or dressings with fluid retention members having more than one layer with different fluid retention characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0465—Tracheostomy tubes; Devices for performing a tracheostomy; Accessories therefor, e.g. masks, filters
- A61M16/047—Masks, filters, surgical pads, devices for absorbing secretions, specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
- A61F2013/00229—Wound bandages not adhering to the wound with alginate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00251—Wound bandages in a special way pervious to air or vapours with macroscopic openings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00412—Plasters use for use with needles, tubes or catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00536—Plasters use for draining or irrigating wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00604—Multilayer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00621—Plasters form or structure cast
- A61F2013/00634—Plasters form or structure cast foam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00731—Plasters means for wound humidity control with absorbing pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00731—Plasters means for wound humidity control with absorbing pads
- A61F2013/0074—Plasters means for wound humidity control with absorbing pads containing foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00748—Plasters means for wound humidity control with hydrocolloids or superabsorbers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/45—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
- A61F2013/4506—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape special configurations using catheter or tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F2013/530481—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
Definitions
- This invention relates to a dressing for a surgical drain, for instance a chest drain, and in particular to such a dressing that is capable of absorbing exudate from the drain site.
- a surgical drain is a tube used by surgeons to remove pus, blood or other fluids which may accumulate and become a focus of infection. Drains may be connected to a source of suction or may be allowed to drain naturally. The drain may remain in place for extended periods, for instance days or even weeks, and a suitable dressing is usually applied around it.
- drains are not without disadvantages, notably the fact that the drain may allow infection into the wound. However, in some clinical situations their use is unavoidable.
- One particular form of surgical drain is a chest drain, a flexible plastic tube that is inserted through the chest wall and into the pleural space to remove air, fluid or pus from the intra-thoracic space.
- Chest drains are commonly made from clear plastics like PVC and soft silicone, and have diameters of from a few millimetres to one centimetre or more.
- a major problem with the use of chest drains is clogging of the drain, and this often leads to the use of larger diameter tubes.
- larger drains require larger incisions to be made in the patient's skin, and this in turn may increase the amount of body fluid that exudes from the incision around the drain tube. If that body fluid is allowed to accumulate it may lead to increased risk of infection, as well as requiring more frequent dressing changes, which may cause discomfort to the patient.
- dressings for surgical drains that provide for improved management of wound exudate at the drain site, and thereby lead to reduced risk of infection, reduced frequency of dressing changes, and/or other benefits in relation to the prior art.
- a dressing for a surgical drain comprising an absorbent body adapted to be fitted around the drain at a site at which the drain emerges from a patient's body, wherein the absorbent body comprises a base of open-celled foam and a cover member bonded to the base so as to form a substantially enclosed compartment between the cover member and the base, which compartment contains a superabsorbent material, and wherein exudate at said site is able to flow via the base member to the compartment and to be absorbed by the superabsorbent material within the compartment.
- the dressing according to the invention is advantageous primarily in that it provides for effective absorption of exudate emitted from the drain site. Exudate is transported away from that site by the wicking action of the foam base and is absorbed by the superabsorbent material. High quantities of exudate may be absorbed before the dressing needs to be changed, thereby reducing the frequency of dressing changes required.
- the absorbent body may have any suitable shape and dimensions, depending on the nature of the drain about which the dressing is to be applied, the part of the body to which it is to be applied, etc.
- the absorbent body will be generally circular.
- the absorbent body most preferably is formed with a slot or the like that extends from the perimeter of the absorbent body to a suitable position within the absorbent body, most commonly a substantially central position.
- the slot is thus typically a radial slot, extending from the centre of the absorbent body to its perimeter.
- the slot may terminate in an opening, the dimensions of which are preferably such that the drain is closely received within it, so that the wall of the opening fits closely against the drain.
- the opening may be provided with outwardly extending radial slits.
- the base of the absorbent body comprises an open-celled foam.
- the foam may be any suitable foam known in the art.
- the foam is a hydrophilic foam. More preferably, the hydrophilic foam is a polyurethane foam. Most preferably, the foam is an open-celled polyurethane foam.
- the open cellular structure of the foam allows exudate from the drain site to pass through it.
- the foam typically has a thickness of 0.5mm to 10mm, preferably from 1 mm to 5mm, or from 1 mm to 3mm, and the foam most preferably has a thickness of about 1 mm, about 2mm, or about 3mm.
- the foam may incorporate an anti-microbial agent.
- One antimicrobial agent that may be incorporated into the foam is silver.
- metallic silver being relatively unreactive, ionic silver has been shown to have antimicrobial activity and has been previously used in wound dressings.
- positively charged silver ions bind to negatively charged sites on proteins and nucleic acids in bacteria. This causes a number of effects, including alteration of the protein structure, rupture of the cell wall and/or cell death. It is believed that silver ions have multiple attack sites, interacting with a number of different functional groups in bacteria, including thiol groups,
- the incorporation of silver into the foam results in the sustained release of low concentrations of silver ions over time. Such a slow release has been shown to stimulate healing and inhibit the growth of micro-organisms.
- Any suitable method or form of silver known in the art may be used in the present invention.
- the silver may be in the form of silver sulphadiazine.
- Another antimicrobial that may be incorporated into the foam is
- PHMB polyhexamethylene biguanide
- COSMOCIL® CQ polyhexamethylene biguanide
- the cover member that is bonded to the foam base in order to create the compartment may be of any suitable material. Such materials will typically be synthetic textile materials.
- a preferred material is a heat-fusible non-woven web, eg of the type known as "dryweb", which may be of polyester.
- Bonding of the cover member and the base may be brought about by any suitable means.
- the parts of one or both of the juxtaposed surfaces of those components that are to be bonded together may be coated with a suitable adhesive, and the two components then pressed together.
- the two components are bonded by using a fusible web material for the cover member, and apply heat and pressure to that material in the regions in which it is to be bonded to the foam.
- a fusible web material for the cover member, and apply heat and pressure to that material in the regions in which it is to be bonded to the foam.
- cover member and foam base both having the shape and dimensions of the finished absorbent body, may be bonded together as just described, with superabsorbent material previously having been positioned between them, in the region that constitutes the compartment of the finished absorbent body.
- superabsorbent material previously having been positioned between them, in the region that constitutes the compartment of the finished absorbent body.
- superabsorbent material is encapsulated between the two sheets, and then cutting individual absorbent bodies from the bonded sheets.
- the features necessary to permit the absorbent body to be fitted around a drain may also be formed during the cutting operation, but may alternatively be introduced later, after assembly of the dressing.
- the absorbent body is generally circular, with a radial slot extending from one point on the perimeter of the absorbent body to a central opening.
- the cover member is bonded to the foam base around the perimeter of the circle, along the margins of the slot, and around the central opening.
- the resulting compartment is generally C-shaped.
- the compartment contains superabsorbent material.
- Superabsorbent material in the context of the present invention means a material that is capable of absorbing many times its own mass of water (eg more than 100 times, and up to 200, 300, 400, 500 or more times its own mass of water).
- the absorbent body of the present invention may comprise any superabsorbent material
- preferred superabsorbent materials are polymeric superabsorbent materials and include alginate, polyacrylate (ie a salt of polyacrylic acid), polyacrylamide copolymers, ethylene maleic anhydride copolymer, carboxymethylcellulose, polyvinylalcohol copolymers, polyethylene oxide and starch -grafted copolymers of polyacrylonitrile.
- the particles may be incorporated into a carrier material, for instance by being encapsulated between two layers of carrier material, eg tissue paper or the like.
- An alginate superabsorbent may be sodium or calcium alginate.
- Alginate superabsorbent is preferably in the form of a non-woven mat.
- the most preferred superabsorbent material is sodium polyacrylate polymer.
- Sodium polyacrylate polymer is a solid crystalline material, and is preferably incorporated into a layer in the form of particles encapsulated between two layers of carrier material, such as tissue paper.
- carrier material such as tissue paper.
- a specific example of a suitable material is Gelok® 14040S/S manufactured by Gelok International Corporation.
- Superabsorbent materials comprising particles of super-absorbing polymer encapsulated between two layers of carrier material can be cut into shapes adapted to fit into the compartment of the absorbent body.
- the compartment is generally C-shaped
- a similarly-shaped pice of the superabsorbent material can be accommodated within the compartment.
- the dressing of the invention will generally also comprise an adhesive skin contact layer, and a backing layer that forms a liquid- impermeable top surface of the dressing.
- the absorbent body will generally be held between the backing layer and the skin contact layer.
- the skin contact layer is the part of the dressing that, in use, is applied to the patient's skin, and will generally carry an adhesive. It is generally preferable that the adhesive that is used is one that is non-adherent and permits the wound dressing to be removed relatively easily and without causing trauma to the drain site and surrounding skin.
- the adhesive may be, for instance, a hydrocolloid adhesive, a polyurethane adhesive, a hydrogel or, most preferably, a silicone adhesive, particularly a silicone gel.
- Silicone adhesives offer numerous advantages. Most preferably, the silicone adhesive is in the form of a silicone gel of the type generally referred to as a "soft silicone".
- Soft silicone adhesives are particularly suited for use as skin contact layers in wound dressings. They are soft, tactile and conformable, and exhibit good adhesion to dry skin but low adherence to an underlying wound. Thus, the dressing can be applied to a wound and subsequently removed without causing trauma to the wound. Silicone gels are adhesive but do not leave residue on a surface/substrate when removed.
- Silicone gels suitable for use as skin contact materials in the present invention may be carried on a layer of melt-blown non-woven material, eg a sheet of melt-blown polyurethane (MBPU), as described in WO2007/1 13597.
- a layer of melt-blown non-woven material eg a sheet of melt-blown polyurethane (MBPU), as described in WO2007/1 13597.
- the reverse side of the MBPU may be coated with an adhesive, eg an acrylic adhesive, to affix the silicone gel/MBPU laminate to overlying
- an adhesive eg an acrylic adhesive
- components of the dressing eg to the absorbent body and/or a backing layer of the form described below.
- the skin contact layer generally extends beyond the absorbent body, to provide a greater contact area between the dressing and the skin. Thus, a border is provided around the absorbent body.
- the adhesive may be provided only on the parts of the skin contact layer that form the border around the absorbent body. More commonly, however, the skin contact adhesive is present across the full extent of the dressing.
- the skin contact layer is preferably provided with perforations to increase breathability of the dressing, and so lessen the likelihood of maceration of the skin to which the dressing is applied.
- the perforations may also provide for greater ease of removal of the dressing, and improved flexibility and conformity.
- the dressing according to the invention typically comprises a backing layer, which forms a barrier between the wound and the surrounding atmosphere. Any suitable material known in the art may be used for the backing layer.
- the backing layer will generally be impermeable to exudate and other liquids, but is preferably permeable to air and moisture vapour.
- the backing layer preferably exhibits a relatively high moisture vapour transmission rate (MVTR). 2
- the MVTR of the backing layer may be at least 300g/m /24h, more suitably at least 500g/m 2 /24h and preferably at least 700g/m 2 /24h at 37 °C and 100% to 10% relative humidity difference.
- the backing layer is most preferably a plastics film having the desired
- the backing layer may be a polyurethane film.
- the backing layer will generally be of the same dimensions as the skin contact layer, that is to say it will generally be larger in size than the absorbent body, such that it extends beyond the edge of the absorbent body on one or more sides.
- the backing layer extends beyond the edge of the absorbent body on all sides, forming a border around the absorbent body, and is bonded to the peripheral region of the skin contact layer.
- the underside of the backing layer may carry an adhesive, eg an acrylic adhesive, to bond the backing layer to underlying components of the dressing, eg to the upper surface of the absorbent body and to the peripheral region of the skin contact layer.
- an adhesive eg an acrylic adhesive
- the skin contact layer may be provided with relatively large openings in order to expose the skin to the adhesive on the underside of the backing layer.
- That adhesive eg acrylic adhesive
- the typically nonadherent adhesive eg silicone gel
- the backing layer may constitute the cover member of the compartment, ie the backing layer may be affixed directly to the foam base, with the compartment being the space between the foam base and the backing layer.
- the dressing will generally be supplied with a releasable liner on its underside.
- the releasable liner may cover the adhesive portions of the dressing prior to use, and be removed from the dressing immediately before application of the dressing. This reduces the risk of contamination of the dressing and facilitates handling of the dressing.
- releasable liners are commonly used on dressings known in the art, and suitable materials which can be employed in the present invention will be familiar to the skilled worker.
- the releasable liner may be of a suitable plastics sheet or a siliconised paper or the like.
- the releasable liner may be a single sheet which covers the underside of the dressing, or may be formed of two or more sheets.
- the releasable liner may further comprise one or more tabs to enable the liner to be easily removed from the dressing before use.
- the parts may either overlap or abut and extend outwards from the dressing, thus providing an easy method for removal of the releasable liner.
- Figure 1 is a plan view of a dressing according to the invention.
- Figure 2 is an underside plan view of the dressing of Figure 1 , partially cut away;
- Figure 3 is a cross-sectional view (on an enlarged vertical scale for clarity) on the line Ill-Ill in Figure 1 ;
- Figure 4 is a plan view of an absorbent body forming part of the dressing of Figures 1 to 3, showing hidden detail.
- a chest drain dressing according to the invention is generally designated 1 , and is circular in form, with a diameter of approximately 15cm.
- the dressing 1 has a central opening 10 that is connected to the edge of the dressing 1 by an elongate slot 12.
- a chest drain is received within the opening 10 such that the walls of the opening abut the drain.
- a number of short slits 14 extend outwardly from the opening 1 0, in order to enable the dressing 1 to be fitted around a larger diameter drain.
- the dressing 1 comprises a backing layer 16 that constitutes the top (ie non-skin- facing) surface of the dressing 1 , an adhesive skin contact layer 18 that, prior to use, is covered by a three part release liner 20a-c, and an absorbent body 22, the outline of which is shown in Figure 1 , and the structure of which is described in more detail below, with reference to Figures 3 and 4.
- the backing layer 16 is transparent, with the result that features of the underlying components (ie the absorbent body 22 and the skin contact layer 18) are visible through it.
- the skin contact layer 18 is provided with a regular array of small and large perforations 24a,24b (see Figure 2).
- these perforations are shown as hidden detail only in part of the drawing, though in reality they would be visible around the full periphery of the dressing 1 .
- the backing layer 16 could alternatively be opaque, in which case these underlying features would not be visible when the dressing 1 is viewed from above, as in Figure 1 .
- the skin contact layer 18 is in the form of a sheet of melt-blown polyurethane that is impregnated with and coated on its underside (as viewed in Figure 3) with a silicone gel non-adherent adhesive, as described in WO2007/1 13597.
- the skin contact layer 18 is of the same dimensions as the backing layer 16, such that the skin contact layer 18 and backing layer 16 form a border around the periphery of the dressing 1 .
- the absorbent body 22 comprises three components: a foam base 32, a cover 34 and a superabsorbent 36.
- the foam base 32 is of hydrophilic, open-celled polyurethane foam and is generally circular in shape, save for a radial cut-out 33 that, in the assembled dressing 1 , is aligned with the slot 12.
- the foam base 32 is also provided with a central opening 10a that constitutes part of the central opening 10 of the assembled dressing.
- the foam base 32 has a thickness of approximately 2mm.
- the cover 34 is a sheet of fusible polyester web that is bonded (by the application of heat and pressure) to the upper surface of the foam base 32 around the periphery of the base 32, along the margins of the cut-out 33 and around the central opening 10a.
- the regions over which the cover 34 is bonded to the foam base 32 are indicated by "x" markings in Figure 4.
- a generally C-shaped compartment is thus defined between the cover 34 and the foam base 32, and this is occupied by the correspondingly-shaped
- the superabsorbent 36 comprises particulate polyacrylate polymer encapsulated between two sheets of tissue paper.
- the underside of the backing layer 16 is coated with acrylic adhesive by which the backing layer 16 is affixed to the upper surface of the skin contact layer 18 in the border regions of the dressing 1 , and to the upper surface of the absorbent body 22 in the central region of the dressing.
- the large perforations 24b in the skin contact layer around the periphery of the dressing 1 expose the patient's skin to the acrylic adhesive on the underside of the backing layer 16. This provides for more secure attachment of the dressing 1 to the skin, the relatively strong adherence of the acrylic adhesive where it contacts healthy skin not being a problem as the locations at which this occurs are sufficiently distant from the drain site.
- the dressing 1 may be manufactured by a) forming the absorbent body 22, by applying a sheet of cover member
- the release liners 20a-c can be applied to the skin contact layer 18 at any convenient stage of manufacture.
- the features that permit the dressing 1 to be fitted around a chest drain may be formed in the various components prior to assembly of the dressing 1 , but it is generally more convenient for those features to be formed in a subsequent cutting operation, after assembly of the various components as described above. Indeed, the formation of those features may be done as part of a cutting process in which individual finished dressings are cut from a sheet. Individual dressings may then be sterile-packaged, eg by gamma- irradiation or ethylene oxide.
- the dressing 1 is removed from its packaging and the release liners 20a-c removed.
- the parts of the dressing 1 at opposite sides of the slot 12 are moved slightly apart to allow the dressing 1 to be fitted around a chest drain, with the drain occupying the central opening 10 and the skin contact layer 18 facing the patient's skin.
- Those parts of the dressing 1 are then brought back together and the dressing 1 pressed gently into engagement with the patient's skin.
- any fluid escaping from the drain site contacts the exposed edges of the foam base 32 within the central opening 10.
- the fluid is transported by wicking action through the foam base 32 and hence comes into contact with the superabsorbent 36, which absorbs the fluid, swelling as it does so.
- the backing layer 16 is sufficiently thin and deformable to accommodate that swelling. Accumulation of fluid at the drain site is thereby avoided, and the frequency of required dressing changes and the risk of infection at the drain site are reduced.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Materials For Medical Uses (AREA)
Abstract
L'invention concerne un pansement, pour un drain chirurgical, qui peut absorber un exsudat provenant du site de drain. Le pansement comporte un corps absorbant, conçu pour être ajusté autour du drain à un site auquel le drain émerge du corps d'un patient, le corps absorbant comportant une base de mousse à cellules ouvertes et un élément de revêtement collé à la base de façon à former un compartiment sensiblement fermé entre l'élément de revêtement et la base. Le compartiment contient un matériau super absorbant et l'exsudat, au niveau du site de plaie, peut s'écouler par l'intermédiaire de l'élément de base vers le compartiment et être absorbé par le matériau super absorbant à l'intérieur du compartiment.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1408550.0 | 2014-05-14 | ||
GB1408550.0A GB2526267B (en) | 2014-05-14 | 2014-05-14 | Dressing for surgical drain |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015173546A1 true WO2015173546A1 (fr) | 2015-11-19 |
Family
ID=51032755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2015/051364 WO2015173546A1 (fr) | 2014-05-14 | 2015-05-08 | Pansement pour drain chirurgical |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2526267B (fr) |
WO (1) | WO2015173546A1 (fr) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018226328A1 (fr) * | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Interface tissulaire comprenant de multiples couches |
CN109985305A (zh) * | 2019-04-09 | 2019-07-09 | 徐州市妇幼保健院 | 一种防液体渗漏性强的敷贴 |
US20200101192A1 (en) * | 2018-09-30 | 2020-04-02 | Alexander Folwarzny | Wound dressing |
US10968543B2 (en) | 2011-12-01 | 2021-04-06 | Convatec Technologies Inc. | Wound dressing for use in vacuum therapy |
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
CN113576759A (zh) * | 2021-08-20 | 2021-11-02 | 乔晓雪 | 一种吸收敷料及其应用 |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
GB2617807A (en) * | 2021-12-01 | 2023-10-25 | Brightwake Ltd | Dressing for a medical tube |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089265A2 (fr) * | 2003-04-10 | 2004-10-21 | Bristol-Myers Squibb Company | Pansement de plaies |
DE102008034363A1 (de) * | 2007-08-03 | 2009-02-05 | Birgit Riesinger | Wundpflegeartikel mit absorbierender Hülle |
US20110004172A1 (en) * | 2009-07-06 | 2011-01-06 | Paul Hartmann Ag | Device for vacuum therapy of wounds |
WO2013149078A1 (fr) * | 2012-03-28 | 2013-10-03 | Kci Licensing, Inc. | Systèmes à pression réduite, pansements, et procédés de facilitation de la séparation de parties de composants électroniques et cliniques |
US20130261587A1 (en) * | 2012-03-29 | 2013-10-03 | Principle Business Enterprises, Inc. | Disposable absorbent moisture management dressing |
US20130317406A1 (en) * | 2010-04-16 | 2013-11-28 | Christopher Brian Locke | Dressings and methods for treating a tissue site on a patient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE532495C2 (sv) * | 2007-12-13 | 2010-02-09 | Moelnlycke Health Care Ab | Förband för att skydda huden kring föremål som skjuter ut därifrån |
FR2974004B1 (fr) * | 2011-04-15 | 2014-05-02 | Urgo Lab | Pansement absorbant hydrocellulaire, ses utilisations pour le traitement des plaies chroniques et aigues |
-
2014
- 2014-05-14 GB GB1408550.0A patent/GB2526267B/en not_active Expired - Fee Related
-
2015
- 2015-05-08 WO PCT/GB2015/051364 patent/WO2015173546A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089265A2 (fr) * | 2003-04-10 | 2004-10-21 | Bristol-Myers Squibb Company | Pansement de plaies |
DE102008034363A1 (de) * | 2007-08-03 | 2009-02-05 | Birgit Riesinger | Wundpflegeartikel mit absorbierender Hülle |
US20110004172A1 (en) * | 2009-07-06 | 2011-01-06 | Paul Hartmann Ag | Device for vacuum therapy of wounds |
US20130317406A1 (en) * | 2010-04-16 | 2013-11-28 | Christopher Brian Locke | Dressings and methods for treating a tissue site on a patient |
WO2013149078A1 (fr) * | 2012-03-28 | 2013-10-03 | Kci Licensing, Inc. | Systèmes à pression réduite, pansements, et procédés de facilitation de la séparation de parties de composants électroniques et cliniques |
US20130261587A1 (en) * | 2012-03-29 | 2013-10-03 | Principle Business Enterprises, Inc. | Disposable absorbent moisture management dressing |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US10968543B2 (en) | 2011-12-01 | 2021-04-06 | Convatec Technologies Inc. | Wound dressing for use in vacuum therapy |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
WO2018226328A1 (fr) * | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Interface tissulaire comprenant de multiples couches |
US20200101192A1 (en) * | 2018-09-30 | 2020-04-02 | Alexander Folwarzny | Wound dressing |
US11911525B2 (en) * | 2018-09-30 | 2024-02-27 | Alexander Folwarzny | Wound dressing |
CN109985305A (zh) * | 2019-04-09 | 2019-07-09 | 徐州市妇幼保健院 | 一种防液体渗漏性强的敷贴 |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
CN113576759A (zh) * | 2021-08-20 | 2021-11-02 | 乔晓雪 | 一种吸收敷料及其应用 |
GB2617807A (en) * | 2021-12-01 | 2023-10-25 | Brightwake Ltd | Dressing for a medical tube |
Also Published As
Publication number | Publication date |
---|---|
GB2526267B (en) | 2020-10-28 |
GB2526267A (en) | 2015-11-25 |
GB201408550D0 (en) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015173546A1 (fr) | Pansement pour drain chirurgical | |
EP3072533B1 (fr) | Pansement pour plaies amélioré | |
JP7204685B2 (ja) | 陰圧治療での肉芽形成を促進し浸軟を低減させる複合ドレッシング | |
CA1290210C (fr) | Pansement pour blessures | |
KR102522601B1 (ko) | 의료용 드레싱 | |
EP0006714B1 (fr) | Pansement à perméabilité équilibrée | |
EP1893145B1 (fr) | Pansement | |
EP3479803B1 (fr) | Pansement hybride ayant une grille perforée recouverte d'un gel | |
AU686644B2 (en) | Surgical dressing | |
EP1450740B1 (fr) | Pansement | |
JP2022500106A (ja) | 適応可能接着性創傷被覆材 | |
CA3002890C (fr) | Pansement medical | |
EP3288510B1 (fr) | Pansement | |
GB2531344A (en) | Composite wound dressing | |
GB2525494A (en) | Wound dressing | |
US20140228786A1 (en) | Absorbent body for the therapeutic treatment of a wound by means of negative pressure | |
RU2556779C2 (ru) | Вспомогательное средство для раскроя повязки на рану для вакуум-терапии ран | |
KR101231069B1 (ko) | 구급 반창고 | |
EP1653899B1 (fr) | Feuille absorbante anti-fuites pour pansement | |
GB2526115A (en) | Wound dressing | |
GB2404861A (en) | Absorbant layers for use in wound dressings |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15721814 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15721814 Country of ref document: EP Kind code of ref document: A1 |